I found a French website claiming the drug is BIA 10-2474, with reference to a patient who received an offer to join this trial but decided not to: http://www.b

I found a French website claiming the drug is BIA 10-2474, with reference to a patient who received an offer to join this trial but decided not to: http://www.breizh-info.com/2016/01/15/rennes-biotrial-bialessai-therapeutique/ http://www.breizh-info.com/2016/01/15/rennes-biotrial-biales... And of course, the information around this particular drug is completely missing or intentionally vague. edit: there seems to be a lot of people who believe the drug is a FAAH2 inhibitor, based on previous work from the same company, Bial Pharmaceuticals out of Portugal. The drug works on/around endocannabinoids, which might be why the media was confused about this being cannibis related.